IndiaMTF — home
Stock

Aarti Drugs — MTF Book

AARTIDRUGS · Aarti Drugs Limited
Health Technology

Daily Margin Trading Facility book for Aarti Drugs across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Aarti Drugs’s MTF book?

Aarti Drugs Limited (AARTIDRUGS) has ₹31 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.02% of India’s MTF book, ranking #853. Over 1M (the last 30 trading days) the funded value has risen 1.3%, with the number of shares under margin up 1.2%.

Funded value
₹31 Cr
as of 23 Oct 2026
Rank in book
#853
1,983 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹52 Cr
on 03 Jan 2024
Largest single-day addition
+₹20 Cr
on 10 May 2021
Largest single-day unwind
−₹16 Cr
on 17 May 2021
Free-float market cap
₹1,572 Cr
full market cap ₹3,422 Cr · 45.9% free float · Small cap
MTF share of free float
1.73%
0.8× the median small cap · 2.0× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.35%1.02%1.69%2.36%Feb 2024Oct 2026
View as table: share of free float on margin28 months
Month-end% of free float
23 Oct 20261.728%
30 Sep 20261.773%
31 Aug 20261.953%
31 Jul 20262.127%
30 Jun 20261.523%
29 May 20261.179%
30 Apr 20261.280%
30 Mar 20261.045%
27 Feb 20261.382%
30 Jan 20261.843%
31 Dec 20251.731%
28 Nov 20251.763%
31 Oct 20251.249%
30 Sep 20250.583%
29 Aug 20250.637%
31 Jul 20250.648%
30 Jun 20250.713%
30 May 20250.587%
30 Apr 20250.696%
28 Mar 20250.831%
28 Feb 20250.748%
31 Jan 20250.737%
29 Aug 2024†1.274%
19 Jun 2024†1.148%
31 May 20241.267%
30 Apr 20241.376%
28 Mar 20241.431%
29 Feb 20241.622%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How AARTIDRUGS’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹30 Cr · 97.7%BSE ₹1 Cr · 2.3%

MTF vs Price

Margin-funded outstanding for AARTIDRUGS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹374.90
as of 23 Oct 2026
Price, 1M
−11.5%
adjusted for splits and bonuses
Delivery, 20-day avg
46.7%
of traded volume actually settled
Sessions to unwind
9
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹3−8.6%−8.7%
−69,266
−1.4%unwinding as it falls
10D−₹4−10.5%−10.0%
−80,737
−9.4%unwinding as it falls
1M+₹0+1.3%+1.2%
+8,940
−11.1%building as it falls
3M−₹6−16.4%−18.4%
−1,63,056
−8.6%unwinding as it falls
6M+₹9+44.1%+41.3%
+2,11,625
+0.8%building into strength
1Y+₹11+59.1%+93.6%
+3,50,310
−26.2%building as it falls

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where AARTIDRUGS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

AARTIDRUGS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202631−₹30.02%853
22 Oct 202634−₹00.02%822
21 Oct 202634−₹00.02%817
19 Oct 202634−₹00.02%820
16 Oct 202634−₹00.02%820
15 Oct 202635+₹00.02%822
14 Oct 202634+₹00.02%823
13 Oct 202634+₹00.02%823
12 Oct 202634+₹00.02%825
09 Oct 202634+₹00.02%823
08 Oct 202634+₹20.02%822
07 Oct 202633+₹00.02%836
06 Oct 202632+₹00.02%836
05 Oct 202632−₹00.02%835
01 Oct 202632+₹10.02%837
30 Sep 202631−₹00.02%859
29 Sep 202632+₹10.02%859
28 Sep 202631+₹30.02%863
25 Sep 202628+₹00.02%902
24 Sep 202628+₹10.02%912
23 Sep 202627−₹00.02%922
22 Sep 202627−₹00.02%914
21 Sep 202628−₹10.02%906
18 Sep 202628+₹00.02%890
17 Sep 202628−₹00.02%900
16 Sep 202628−₹00.02%895
15 Sep 202628−₹00.02%896
11 Sep 202629−₹00.02%895
10 Sep 202629−₹10.02%892
09 Sep 202630—0.02%873

AARTIDRUGS within Health Technology

Ranked #52 of 61 funded Health Technology stocks, carrying 0.5% of that sector’s margin book. Its 1.73% of free float on margin is 1.9× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
50SAIPARENTSai Parenterals₹320.5%2.81%+18.2%
51WINDLASWindlas Biotech₹310.5%4.36%+5.7%
52AARTIDRUGSAarti Drugs₹310.5%1.73%+1.3%
53ALKEMAlkem Laboratories₹280.4%0.09%−13.1%
54ASTRAZENAstraZeneca Pharma India₹270.4%0.57%−13.8%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.